Opus Genetics IRD Exercised (in dollars per share)
Exercised (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's exercised (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opus Genetics's exercised (in dollars per share)?
- Opus Genetics (IRD) reported exercised (in dollars per share) of $0.00 in Q1 2026.
- What does exercised (in dollars per share) mean?
- The specific exercise price associated with the conversion of equity instruments into common stock during the period. This metric provides transparency into the cost basis for holders exercising their rights. It is essential for modeling the potential cash proceeds and dilution impact from outstanding equity-linked securities.